• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物 β-葡萄糖醛酸苷酶水凝胶珠激活化学治疗前药。

Microbial β-Glucuronidase Hydrogel Beads Activate Chemotherapeutic Prodrug.

机构信息

Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 60801, United States.

Cancer Center at Illinois, Carle-Illinois College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois 60801, United States.

出版信息

ACS Appl Mater Interfaces. 2024 Jun 5;16(22):28093-28103. doi: 10.1021/acsami.4c02568. Epub 2024 May 22.

DOI:10.1021/acsami.4c02568
PMID:38775441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11164065/
Abstract

Bacteria-assisted chemotherapeutics have been highlighted as an alternative or supplementary approach to treating cancer. However, dynamic cancer-microbe studies at the level have remained a challenge to show the impact and effectiveness of microbial therapeutics due to the lack of relevant coculture models. Here, we demonstrate a hydrogel-based compartmentalized system for prodrug activation of a natural ingredient of licorice root, glycyrrhizin, by microbial β-glucuronidase (GUS). Hydrogel containment with provides a favorable niche to encode GUS enzymes with excellent permeability and can serve as an independent ecosystem in the transformation of pro-apoptotic materials. Based on the confinement system of GUS expressing microbes, we quantitatively evaluated chemotherapeutic effects enhanced by microbial GUS enzyme in two dynamic coculture models (i.e., 2D monolayered cancer cells and 3D tumor spheroids). Our findings support the processes of prodrug conversion mediated by bacterial GUS enzyme which can enhance the therapeutic efficacy of a chemotherapy drug under dynamic coculture conditions. We expect our coculture platforms can be used for the evaluation of pharmacological properties and biological activity of xenobiotics as well as the potential impact of microbes on cancer therapeutics.

摘要

细菌辅助化疗已被强调为治疗癌症的一种替代或补充方法。然而,由于缺乏相关的共培养模型,在水平上进行动态的癌症-微生物研究一直是展示微生物治疗效果和有效性的挑战。在这里,我们展示了一种基于水凝胶的分隔系统,用于通过微生物β-葡萄糖醛酸酶(GUS)激活甘草根的天然成分甘草酸的前药。用提供水凝胶容纳物,为编码具有优异渗透性的 GUS 酶提供了有利的小生境,并可以作为转化促凋亡物质的独立生态系统。基于表达 GUS 的微生物的封闭系统,我们在两种动态共培养模型中定量评估了微生物 GUS 酶增强的化疗效果(即 2D 单层癌细胞和 3D 肿瘤球体)。我们的研究结果支持细菌 GUS 酶介导的前药转化过程,该过程可以增强化疗药物在动态共培养条件下的治疗效果。我们期望我们的共培养平台可用于评估外源性物质的药理学特性和生物活性以及微生物对癌症治疗的潜在影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/6401245ba122/am4c02568_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/9c3ab7d9014b/am4c02568_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/fca4de5cb419/am4c02568_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/9789fa60048e/am4c02568_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/46bcfa620e74/am4c02568_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/6401245ba122/am4c02568_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/9c3ab7d9014b/am4c02568_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/fca4de5cb419/am4c02568_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/9789fa60048e/am4c02568_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/46bcfa620e74/am4c02568_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b35/11164065/6401245ba122/am4c02568_0005.jpg

相似文献

1
Microbial β-Glucuronidase Hydrogel Beads Activate Chemotherapeutic Prodrug.微生物 β-葡萄糖醛酸苷酶水凝胶珠激活化学治疗前药。
ACS Appl Mater Interfaces. 2024 Jun 5;16(22):28093-28103. doi: 10.1021/acsami.4c02568. Epub 2024 May 22.
2
A β-glucuronidase-responsive albumin-binding prodrug for potential selective kinase inhibitor-based cancer chemotherapy.一种β-葡糖苷酸酶响应型白蛋白结合前药,用于潜在的基于选择性激酶抑制剂的癌症化疗。
Eur J Med Chem. 2018 Oct 5;158:1-6. doi: 10.1016/j.ejmech.2018.08.100. Epub 2018 Sep 3.
3
Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue.通过细胞外激活高活性糖苷型柔红霉素类似物进行选择性癌症治疗。
Mol Pharm. 2013 May 6;10(5):1773-82. doi: 10.1021/mp300581u. Epub 2013 Mar 26.
4
Induction of β-glucuronidase release by cytostatic agents in small tumors.细胞抑制剂在小肿瘤中诱导β-葡糖苷酸酶释放。
Mol Pharm. 2012 Nov 5;9(11):3277-85. doi: 10.1021/mp300327w. Epub 2012 Oct 11.
5
Design, synthesis and in vitro evaluation of β-glucuronidase-sensitive prodrug of 5-aminolevulinic acid for photodiagnosis of breast cancer cells.β-葡萄糖醛酸酶敏感型 5-氨基酮戊酸前药的设计、合成及体外评价用于乳腺癌细胞的光诊断。
Bioorg Chem. 2018 Aug;78:372-380. doi: 10.1016/j.bioorg.2018.03.020. Epub 2018 Mar 30.
6
Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate.当多柔比星作为前药DOX-GA3与单克隆抗体β-葡萄糖醛酸酶缀合物联合使用时,具有显著的抗肿瘤功效。
Int J Cancer. 2001 Feb 15;91(4):550-4. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1075>3.0.co;2-l.
7
Beta-glucuronidase-mediated drug release.β-葡萄糖醛酸酶介导的药物释放。
Curr Pharm Des. 2002;8(15):1391-403. doi: 10.2174/1381612023394485.
8
Synthesis and evaluation of [18F]-FEAnGA as a PET Tracer for beta-glucuronidase activity.合成与评价 [18F]-FEAnGA 作为 β-葡萄糖醛酸酶活性的 PET 示踪剂。
Bioconjug Chem. 2010 May 19;21(5):911-20. doi: 10.1021/bc9004602.
9
Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity.用于抗体导向酶前药疗法(ADEPT)的免疫脂质体作为酶载体(免疫酶体):前药激活能力的优化。
Pharm Res. 1996 Apr;13(4):604-10. doi: 10.1023/a:1016010524510.
10
A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironment.一种在肿瘤微环境中具有增强的葡糖苷酸前药激活活性的人源化免疫酶。
Bioconjug Chem. 2011 May 18;22(5):938-48. doi: 10.1021/bc1005784. Epub 2011 Apr 12.

本文引用的文献

1
Dynamic Effect of β-Lactam Antibiotic Inactivation Due to the Inter- and Intraspecies Interaction of Drug-Resistant Microbes.β-内酰胺类抗生素因耐药微生物的种间和种内相互作用而失活的动态效应。
ACS Biomater Sci Eng. 2024 Mar 11;10(3):1461-1472. doi: 10.1021/acsbiomaterials.3c01678. Epub 2024 Feb 5.
2
Toxicity of per- and polyfluoroalkyl substances to microorganisms in confined hydrogel structures.在受限水凝胶结构中,全氟和多氟烷基物质对微生物的毒性。
J Hazard Mater. 2023 Aug 15;456:131672. doi: 10.1016/j.jhazmat.2023.131672. Epub 2023 May 22.
3
Tumor-Targeting Nanoassembly for Enhanced Colorectal Cancer Therapy by Eliminating Intratumoral .
用于通过消除肿瘤内环境来增强结直肠癌治疗的肿瘤靶向纳米组装体
ACS Appl Mater Interfaces. 2023 Mar 14. doi: 10.1021/acsami.3c01210.
4
Simultaneous Knockdown of Immune Suppressive Markers by Tumor Microenvironment-Responsive Multifaceted Prodrug Nanomedicine.肿瘤微环境响应型多功能前药纳米医学同时敲低免疫抑制标志物。
ACS Appl Mater Interfaces. 2023 Mar 15;15(10):12864-12881. doi: 10.1021/acsami.3c00986. Epub 2023 Mar 1.
5
Hierarchical encapsulation of bacteria in functional hydrogel beads for inter- and intra- species communication.功能水凝胶珠中细菌的分层包封用于种间和种内通讯。
Acta Biomater. 2023 Mar 1;158:203-215. doi: 10.1016/j.actbio.2023.01.003. Epub 2023 Jan 9.
6
Soft hydrogel-shell confinement systems as bacteria-based bioactuators and biosensors.作为基于细菌的生物致动器和生物传感器的柔软水凝胶壳限制系统。
Biosens Bioelectron. 2023 Jan 1;219:114809. doi: 10.1016/j.bios.2022.114809. Epub 2022 Oct 14.
7
Flipped Well-Plate Hanging-Drop Technique for Growing Three-Dimensional Tumors.用于培养三维肿瘤的翻转孔板悬滴技术
Front Bioeng Biotechnol. 2022 Jul 4;10:898699. doi: 10.3389/fbioe.2022.898699. eCollection 2022.
8
The role of gut microbial β-glucuronidase in drug disposition and development.肠道微生物β-葡萄糖醛酸酶在药物处置和开发中的作用。
Drug Discov Today. 2022 Oct;27(10):103316. doi: 10.1016/j.drudis.2022.07.001. Epub 2022 Jul 9.
9
Multi-layered alginate hydrogel structures and bacteria encapsulation.多层藻酸盐水凝胶结构和细菌包封。
Chem Commun (Camb). 2022 Jul 28;58(61):8584-8587. doi: 10.1039/d2cc01187e.
10
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.铜绿假单胞菌:发病机制、毒力因子、抗生素耐药性、与宿主的相互作用、技术进展和新兴治疗方法。
Signal Transduct Target Ther. 2022 Jun 25;7(1):199. doi: 10.1038/s41392-022-01056-1.